CollPlant Biotechnologies (CLGN) vs Curanex Pharmaceuticals (CURX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Curanex Pharmaceuticals is the larger company by market cap ($8.3 million vs $6.6 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLGN | CURX |
|---|---|---|
| Share price | $3.51 | $5.31 |
| Market cap | $6.64M | $8.33M |
| 1-day change | -11.59% | +11.55% |
| EPS (TTM) | $-9.33 | $-7.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $26.80 | $16.94 |
| 52-week low | $2.64 | $3.58 |
| Distance from 52-week high | -86.90% | -68.65% |
| Average volume | 352.86K | 19.85K |
| Shares outstanding | 1.89M | 1.57M |
| Employees | 39 | 6 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About CollPlant Biotechnologies
CLGN stock →CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology.
Health Care · Industrial Specialties · 39 employees
About Curanex Pharmaceuticals
CURX stock →Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
CLGN vs CURX FAQ
Which is bigger, CollPlant Biotechnologies or Curanex Pharmaceuticals?
Curanex Pharmaceuticals (CURX) is larger, with a market capitalization of $8.33M compared with $6.64M for CollPlant Biotechnologies (CLGN).
Are CollPlant Biotechnologies and Curanex Pharmaceuticals in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for CollPlant Biotechnologies and Biotechnology: Pharmaceutical Preparations for Curanex Pharmaceuticals.